0001752724-20-070734.txt : 20200415 0001752724-20-070734.hdr.sgml : 20200415 20200415133142 ACCESSION NUMBER: 0001752724-20-070734 CONFORMED SUBMISSION TYPE: NT N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200415 DATE AS OF CHANGE: 20200415 EFFECTIVENESS DATE: 20200415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HIGHLAND INCOME FUND\MA CENTRAL INDEX KEY: 0001710680 IRS NUMBER: 456245636 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: NT N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-23268 FILM NUMBER: 20793231 BUSINESS ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 972-628-4100 MAIL ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: HIGHLAND FLOATING RATE OPPORTUNITIES FUND DATE OF NAME CHANGE: 20170925 FORMER COMPANY: FORMER CONFORMED NAME: HIGHLAND FLOATING RATE OPPORTUNITIES FUND II DATE OF NAME CHANGE: 20170628 N-CEN 1 primary_doc.xml X0201 N-CEN LIVE 0001710680 XXXXXXXX 811-23268 N-2 HIGHLAND INCOME FUND\MA 811-23268 0001710680 254900CMUE9FRYL2UR80 200 CRESCENT COURT SUITE 700 SUITE 700 DALLAS 75201 US-TX US 1-877- 665-1287 American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn 11219 1-800-937-5449 Records As Transfer Agent For Trust SEI Investments Global Funds Services 1 Freedom Valley Drive Oaks 19456 1-610-676-1000 Records as Administrator for Trust NexPoint Securities, Inc. 300 Crescent Court Suite 700 Dallas 75201 1-972-628-4100 Records as Distributor for Trust Highland Capital Management Fund Advisors, L.P. 300 Crescent Court Suite 700 Dallas 75201 1-877-665-1287 Records as Advisor and Administrator for Trust The Bank of New York Mellon 240 Greenwich Street New York 10286 1-212-495-1784 Records as Custodian for Trust N N N-2 Y Dr. Bob Froehlich N/A N Dustin Norris 006624477 Y Ethan Powell N/A N Bryan A. Ward N/A N John Honis N/A N Jason Post N/A 200 Crescent Court, Suite 700 Dallas 75201 XXXXXX N N N N N NexPoint Securities, Inc. 8-69128 000165013 N/A Y N PRICEWATERHOUSECOOPERS, LLP 238 5493009NI73B74CHXG16 N N N N N N Highland Income Fund 254900CMUE9FRYL2UR80 N 1 0 0 N/A Y N Y N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N/A N/A N/A N/A N N Y N Highland Capital Management Fund Advisors, L.P. 801-69968 000149653 5493002K2NSYVU046L11 N American Stock Transfer & Trust Company, LLC 084-00416 254900TS5EWP83BEOU02 N N N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Pricing Direct 549300WIC0TOJ7N7GD54 N S&P 549300U4VWNITEKO2881 N IHS Markit 549300HLPTRASHS0E726 GB N Thomson Reuters Corporation 549300561UZND4C7B569 CA N Bloomberg 254900BF4G8VMW8GG471 N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Y American Stock Transfer & Trust Company, LLC 254900TS5EWP83BEOU02 N N N Highland Capital Management Fund Advisors, L.P. 5493002K2NSYVU046L11 Y N SEI INVESTMENTS GLOBAL FUNDS SERVICES 801-24593 SEC FILE NUMBER N N N NexPoint Securities, Inc. 8-69128 000165013 N/A 0 J.P. MORGAN SECURITIES 008-35008 000000079 ZBUT11V806EZRVTWT807 92875.26 JONES & ASSOCIATES 8-26089 000106861 N/A 7051.47 SOCIETE GENERALE COWEN SECURITIES CORP. 008-40756 000023857 5493008QI0EFC5WBED75 115434 NEWEDGE USA, LLC 008-66125 000128351 549300F35UE0BOM1WJ55 26829 ROYAL BANK CANADA 008-55108 000112284 213800IMQDJ1OL5HD458 CA 251600 ITG 008-44218 000029299 549300S41SMIODVIT266 7569.23 CANTOR FITZGERALD & CO. 008-00201 000000134 5493004J7H4GCPG6OB62 46241 JEFFERIES LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 3250 BTIG LLC 008-65473 000122225 549300GTG9PL6WO3EC51 5115.41 BNP PARIBAS 008-32682 000015794 RCNB6OTYUAMMP879YW96 51232 617431.85 GOLDMAN, SACHS & CO. 008-00129 000000361 FOR8UP27PHTHYVLBNG30 94264720 DEUTSCHE BANK SECURITIES, INC. 008-17822 000002525 9J6MBOOO7BECTDTUZW19 30713503.75 J.P. MORGAN SECURITIES 008-35008 000000079 ZBUT11V806EZRVTWT807 120272568.81 MORGAN STANLEY & CO, INC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 91730468.41 BAIRD, ROBERT W., & CO., INCORPORATED 008-00497 000008158 549300772UJAHRD6LO53 26160087.5 BARCLAYS CAPITAL INC. 008-41342 000019714 AC28XWWI3WIBK2824319 49215902 NOMURA 008-15255 000004297 OXTKY6Q8X53C9ILVV871 83951677 WELLS FARGO 008-65876 000126292 VYVVCKR63DVZZN70PB21 42419862.16 NATIONAL ALLIANCE CAPITAL, LLC 8-48723 000039455 N/A 28177875 BROWNSTONE 8-29349 000014055 N/A 45092245.68 891769906.91 N 1024031629.5390412 Other Common Common stock N N Common stock N N N 1.14 0.0371 12.43000000 13.88 true false true false false false INTERNAL CONTROL RPT 2 HIF_ICL.txt INTERNAL CONTROL LETTER Report of Independent Registered Public Accounting Firm To the Board of Trustees and Shareholders of Highland Income Fund In planning and performing our audit of the financial statements of Highland Income Fund (the Fund) as of and for the year ended December 31, 2019, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Funds internal control over financial reporting. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A companys internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a companys assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the companys annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted the following deficiency in the Funds internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of December 31, 2019. Controls over the application of fair value accounting with respect to the validation of fair value methodologies were not sufficiently designed to ensure the appropriateness of the fair value determinations reached for Level 3 real estate- related holdings. This report is intended solely for the information and use of the Board of Trustees of Highland Income Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. PricewaterhouseCoopers LLP Dallas, Texas April 10, 2020 LEGAL PROCEEDINGS 3 HFRO_-_G.1.a.txt LEGAL PROCEEDINGS Highland Income Fund Item G.1.a.i. - Legal Proceedings Case or Docket Number: 05-15-01463-CV Full Names of Principal Parties: Claymore Holdings, LLC v. Credit Suisse AG, Cayman Islands Branch and Credit Suisse Securities (USA) LLC Brief Description: Two Highland-managed funds, the NexPoint Strategic Opportunities Fund and the Highland Income Fund, are the beneficiaries of a +$400 million judgment (including accrued interest) against Credit Suisse related to a syndicated real estate transaction fraudulently underwritten by the Swiss bank. Credit Suisse is appealing the judgment against it. The two funds also are participants in a similar action against Credit Suisse related to five additional real estate deals in which the funds allege Credit Suisse committed fraud in relation to the underwriting.